IMNM
ImmunomeANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
IMNM vs peer average
92/100
IMNM vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
IOVA is the first available peer comparator.
Closest provided oncology development-stage benchmark by market capitalization, but its cell-therapy modality and commercial stage differ materially from Immunome’s targeted oncology pipeline.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMNM
Immunome
IOVA
Iovance Biotherapeutics
Grade
A
F
Momentum
78
100
Value
41
41
Sentiment
88
4
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs IOVA
IMNM / IOVA
Grade Position
Above peers
IMNM vs. peer average (A vs. D)
92/100
Momentum
78
IOVAValue
41
IMNMSentiment
88
IMNMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMNM
IOVA is the first peer returned for this comparison set.